I, AOM happy to share the applied Mesothelioma Research Foundation recently announced funding for five mesothelioma research grants.
Having seen firsthand the deadly impact of this disease can have on patients and their families, my colleagues and I understand the critical need for research dollars for mesothelioma. Thank you to the work of the Meso Foundation is in need of being filled, but not fast enough. Each year 3,000 new Americans were newly diagnosed with mesothelioma, a cancer caused by exposure to asbestos fibers.
A remedy can, AOT come soon enough.
base of funding on the basis of an assessment process rigorous peer. This means that all projects are examined and classified by the Advisory Council of organization sciences, OSA. The five were selected from a group of 42 candidates
This year, OSA projects include :.
- A study tries to combine all the genomic data of ten different pleural mesothelioma tumors and discover which genes are really significant in the treatment of disease.
- A study of the way proteins important in the immune system are involved in regulating the response of mesothelioma cells to chemotherapy.
- A study of WT1 peptide / MHS complex and their use as a potential antigen that may help the immune system to detect and kill mesothelioma cells.
- A review of three experiments BAP1 character to how the loss BAP1 can cause mesothelioma to become more vulnerable to targeted therapeutic approaches.
- A project to identify and validate miRNAs as biomarkers and therapeutic targets in diffuse malignant peritoneal mesothelioma.
The five new grants, the total number of grants funded by the Meso Foundation 76 for a cumulative total of $ 7.6 million in funding. As the highest cumulative Meso Foundation donors, the firm has been a proud supporter of the foundation since it began there more than ten years. However, until a cure meso is, more support is needed. Nobody deserves to suffer through a diagnosis of mesothelioma.
For more information on these grants and more, visit the website Foundation, OSA.
